BioMimetic Therapeutics to raise over $50M in stock sale ahead of their expected PMA clearance of the Augment Bone Graft

BioMimetic Therapeutics, Inc. Announces Commencement of Public Offering of Common Stock (Press Release)
...


Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.